ESMO 2024 Highlights: Presenter Vignette – David Tougeron

Prof. David Tougeron

David Tougeron

MD, PhD

Poitiers University Hospital

Abstract# 502O

Pembrolizumab in combination with CAPOX and bevacizumab in patients with microsatellite stable metastatic colorectal cancer and a high immune infiltrate: preliminary results of FFCD 1703 POCHI trial